Insider · CIK 0001090206
Steven A Ledger
Files at SER (Serina Therapeutics, Inc.). First filing -, latest -.
In brief
Steven A Ledger files SEC Form 4 as CEO and director at SER (Serina Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven A Ledger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Common Stock | +10,100 | $1.93 | $19k | 10,100 | May 27, 2026 |
| May 21, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +380,825 | $0.00 | $0 | 380,825 | May 26, 2026 |
| Feb 3, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +230,100 | $0.00 | $0 | 230,100 | Feb 17, 2026 |
| Mar 28, 2025 | SER Serina Therapeutics, Inc. | JOther Common Stock | +95,730 | $0.00 | $0 | 95,730 | Apr 1, 2025 |
| Sep 9, 2024 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +376,388 | $0.00 | $0 | 490,350 | Sep 11, 2024 |
Questions about Steven A Ledger
Answered from the filings on this page, as of the latest one.
Is Steven A Ledger buying or selling?
Steven A Ledger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven A Ledger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven A Ledger has 0.
Where does Steven A Ledger file Form 4?
Steven A Ledger has filed Form 4 at SER (Serina Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.